Tabebuia

Tabebuia avellanedae Lorenz

Bibliografia

  • Anesini C, Perez C. (1993) Screening of plants used in Argentine folk medicine for antimicrobial activity. J Ethnopharmacol. ;39(2):119-28.
  • Binutu OA, Lajubutu BA. (1994) Antimicrobial potentials of some plant species of the Bignoniaceae family. Afr J Med Med Sci. Sep;23(3):269-73.
  • Block J, Sterpick A, Miller W; Wiernik P. (1974) Early clinical studies with lapachol (NSC-11905). Cancer Chemother Rep. ;4(part 2):27-28.
  • Gershon H, Shanks L. (1975) Fungitoxicity of 1,4-naphthoquinones to Candida albicans and Trichophyton mentagrophytes. Can J of Microbio. ;21:1317-1321.
  • Kinghorn AD, Balandrin MA, eds. (1993) Human Medicinal Agents from Plants. Washington, DC: American Chemical Society; :16-17.
  • Muller K, Sellmer A, Wiegrebe W. (1999) Potential antipsoriatic agents: lapacho compounds as potent inhibitors of HaCaT cell growth. J Nat Prod. ;62(8):1134-6.
  • Nakona K, et al. (1993) Iridoids From Tabebuia Avellanedae. Phytochemisty. ;32:371-373.
  • Perez H, et al. (1997) Chemical Investigations and in Vitro Antimalarial Activity of Tabebuia ochracea ssp. Neochrysanta. International Journal of Pharmacognosy. ;35:227-231.
  • Rao MM, Kingston DG. (1982) Plant anticancer agents. XII. Isolation and structure elucidation of new cytotoxic quinones from Tabebuia cassinoides. J Nat Prod. ;45(5):600-4.
  • Schultes RE, Raffauf RF. (1990) The Healing Forest: Medicinal and Toxic Plants of the Northwest Amazonia. Portland, Ore: Dioscorides Press; :107-109.
  • Stevens, P.F. (2001 onwards). Angiosperm Phylogeny Website. Version 5, May 2004 [and more or less continuously updated since]. http://www.mobot.org/MOBOT/research/APweb/
  • Ueda S, Umemura T, Dohguchi K, Matsuzaki T, Tokuda H, Nishino H, Iwashima A. (1994) Production of anti-tumour-promoting furanonaphthoquinones in Tabebuia avellanedae cell cultures. Phytochemistry. 36(2):323-5.